American Journal of Cardiology
Volume 104, Issue 6 , Pages 769-774 , 15 September 2009

Comparison of Blood Glucose Values on Admission for Acute Myocardial Infarction in Patients With Versus Without Diabetes Mellitus

  • Masaharu Ishihara, MD, PhD

      Affiliations

    • Department of Cardiology, Hiroshima City Hospital, Hiroshima, Kumamoto University School of Medicine, Kumamoto, Japan
    • Corresponding Author InformationCorresponding author: Tel: 81-82-221-2291; fax: 81-82-223-1447
    • ,
  • Sunao Kojima, MD, PhD

      Affiliations

    • Department of Cardiovascular Medicine, Kumamoto University School of Medicine, Kumamoto, Japan
    • ,
  • Tomohiro Sakamoto, MD, PhD

      Affiliations

    • Cardiovascular Center, Saiseikai Kumamoto Hospital, Kumamoto, Japan
    • ,
  • Kazuo Kimura, MD, PhD

      Affiliations

    • Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan
    • ,
  • Masami Kosuge, MD, PhD

      Affiliations

    • Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan
    • ,
  • Yujiro Asada, MD, PhD

      Affiliations

    • First Department of Pathology, Miyazaki Medical College, Miyazaki, Japan
    • ,
  • Chuwa Tei, MD, PhD

      Affiliations

    • Department of Cardiovascular Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, Kagoshima, Japan
    • ,
  • Shunichi Miyazaki, MD, PhD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, Kinki University School of Medicine, Osaka, Japan
    • ,
  • Masahiro Sonoda, MD, PhD

      Affiliations

    • Second Department of Cardiology, National Hospital Kyusyu Cardiovascular Center, Kagoshima, Japan
    • ,
  • Kazufumi Tsuchihashi, MD, PhD

      Affiliations

    • Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
    • ,
  • Masakazu Yamagishi, MD, PhD

      Affiliations

    • Division of Cardiology, Kanazawa University Hospital, Kanazawa, Japan
    • ,
  • Mutsunori Shirai, MD, PhD

      Affiliations

    • Department of Microbiology, School of Medicine, Yamaguchi University, Yamaguchi, Japan
    • ,
  • Hisatoyo Hiraoka, MD, PhD

      Affiliations

    • Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan
    • ,
  • Takashi Honda, MD, PhD

      Affiliations

    • Cardiovascular Center, Saiseikai Kumamoto Hospital, Kumamoto, Japan
    • ,
  • Yasuhiro Ogata, MD, PhD

      Affiliations

    • Department of Cardiology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan
    • ,
  • Hisao Ogawa, MD, PhD

      Affiliations

    • Department of Cardiovascular Medicine, Kumamoto University School of Medicine, Kumamoto, Japan
    • ,
  • Japanese Acute Coronary Syndrome Study (JACSS) Investigators

Received 24 February 2009 ,Revised 6 April 2009 ,Accepted 6 April 2009.

References 

  1. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk after myocardial infarction in patients without diabetes: a systematic overview. Lancet. 2000;355:773–778
  2. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol. 2002;40:1748–1754
  3. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med. 2004;164:982–988
  4. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction (Implications for patients with and without recognized diabetes). Circulation. 2005;111:3078–3086
  5. Ishihara M, Kojima S, Sakamoto T, Asada Y, Tei C, Kimura K, et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J. 2005;150:814–820
  6. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005;26:1255–1261
  7. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008;117:1018–1027
  8. Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP, et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;46:178–180
  9. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association diabetes committee of the council on nutrition, physical activity, and metabolism. Circulation. 2008;117:1610–1619
  10. Matsuo S, Imai E, Horio Y, Yasuda Y, Tomita K, Nitta K, et al. Revised equation for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–992
  11. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka Y, et al. Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with an anterior wall first acute myocardial infarction. Am J Cardiol. 2003;92:288–291
  12. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F, et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 2002;51:1076–1082
  13. Williams SB, Goldfine AB, Timimi FK, Roddy MA, Simonson DC, Creager MA. Acute hyperglycemia attenuates endothelium-dependent vasodilation in human in vivo. Circulation. 1998;97:1695–1701
  14. Worthley MI, Holmes AS, Willoughby SR, Kucia AM, Heresztyn T, Stewart S, et al. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes. J Am Coll Cardiol. 2007;49:304–310
  15. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycemia and therapeutic prospects. Diabetologia. 1993;36:1119–1125
  16. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1–7
  17. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, et al. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J. 2003;146:674–678
  18. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–2072
  19. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681–1687
  20. Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res. 1997;34:113–120
  21. Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of hypoglycaemia and cardiac ischaemia: a study based on continuous monitoring. Diabetes Care. 2003;26:1485–1489
  22. Depre C, Vanoverschelde JLJ, Taegtmeyer H. Glucose for the heart. Circulation. 1999;99:578–588
  23. Kahn BB. Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J Clin Invest. 1992;89:1367–1374
  24. Opie LH. Metabolic perturbations in ischemic heart disease. Dialogues Cardiovasc Med. 1996;2:75–82
  25. Malmberg K, Rydén L, Efendic S, Herlitz J, Nicol P, Waldenström A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effect on mortality at 1 year. J Am Coll Cardiol. 1995;26:57–65
  26. The CREATE-ECLA Trial Group. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction (The CREATE-ECLA randomized controlled trial). JAMA. 2005;293:437–446
  27. Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L DIGAMI 2 Investigators. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Eur Heart J. 2008;29:166–176
  28. Norhammar ATenerz Å, Nilsson G, Hamsten A, Efendíc S, Rydén L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140–2144
  29. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T, et al. Is admission hyperglycemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?. Eur Heart J. 2006;27:2413–2419

 This study was supported by the Research Grant for Cardiovascular Disease (14C-4) from the Ministry of Health, Labour and Welfare, Tokyo, Japan.

PII: S0002-9149(09)01038-8

doi: 10.1016/j.amjcard.2009.04.055

American Journal of Cardiology
Volume 104, Issue 6 , Pages 769-774 , 15 September 2009

Article Tools

* Image Usage & Resolution